S2

General Information


DRACP ID  DRACP04023

Peptide Name   S2

Sequence  RRWYWWWYWRR

Sequence Length  11

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C97H118N28O14

Absent amino acids  ACDEFGHIKLMNPQSTV

Common amino acids  W

Mass  207871

Pl  12.04

Basic residues  4

Acidic residues  0

Hydrophobic residues  5

Net charge  4

Boman Index  -4831

Hydrophobicity  -228.18

Aliphatic Index  0

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  30480

Absorbance 280nm  3048

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32328042

Title  Peptides With Triplet-Tryptophan-Pivot Promoted Pathogenic Bacteria Membrane Defects

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  15844

DRACP is developed by Dr.Zheng's team.